55 related articles for article (PubMed ID: 24756753)
21. Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation.
Ann EJ; Kim HY; Choi YH; Kim MY; Mo JS; Jung J; Yoon JH; Kim SM; Moon JS; Seo MS; Hong JA; Jang WG; Shore P; Komori T; Koh JT; Park HS
J Bone Miner Res; 2011 Feb; 26(2):317-30. PubMed ID: 20740684
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3T3-L1 preadipocytes into bone-forming osteoblasts in vitro.
Takahashi T
Calcif Tissue Int; 2011 Apr; 88(4):336-47. PubMed ID: 21258786
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel genes of the bone-specific transcription factor Runx2.
Stock M; Schäfer H; Fliegauf M; Otto F
J Bone Miner Res; 2004 Jun; 19(6):959-72. PubMed ID: 15190888
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel melatonin-binding nuclear receptor: Vitamin D receptor.
Fang N; Hu C; Sun W; Xu Y; Gu Y; Wu L; Peng Q; Reiter RJ; Liu L
J Pineal Res; 2020 Jan; 68(1):e12618. PubMed ID: 31631405
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-145 regulates osteoblastic differentiation by targeting the transcription factor Cbfb.
Fukuda T; Ochi H; Sunamura S; Haiden A; Bando W; Inose H; Okawa A; Asou Y; Takeda S
FEBS Lett; 2015 Oct; 589(21):3302-8. PubMed ID: 26450370
[TBL] [Abstract][Full Text] [Related]
26. Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination.
Hjelmeland AB; Schilling SH; Guo X; Quarles D; Wang XF
Mol Cell Biol; 2005 Nov; 25(21):9460-8. PubMed ID: 16227596
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.
Garimella R; Tadikonda P; Tawfik O; Gunewardena S; Rowe P; Van Veldhuizen P
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28300755
[TBL] [Abstract][Full Text] [Related]
28. Induced pluripotent stem cells from homozygous Runx2-deficient mice show poor response to vitamin D during osteoblastic differentiation.
Aoki H; Suzuki E; Nakamura T; Onodera S; Saito A; Ohtaka M; Nakanishi M; Nishimura K; Saito A; Azuma T
Med Mol Morphol; 2022 Sep; 55(3):174-186. PubMed ID: 35461467
[TBL] [Abstract][Full Text] [Related]
29. The correlated evolution of Runx2 tandem repeats, transcriptional activity, and facial length in carnivora.
Sears KE; Goswami A; Flynn JJ; Niswander LA
Evol Dev; 2007; 9(6):555-65. PubMed ID: 17976052
[TBL] [Abstract][Full Text] [Related]
30. The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression.
Meyer MB; Benkusky NA; Pike JW
J Biol Chem; 2014 Jun; 289(23):16016-31. PubMed ID: 24764292
[TBL] [Abstract][Full Text] [Related]
31. Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass.
McCarty MF; Lewis Lujan L; Iloki Assanga S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563167
[TBL] [Abstract][Full Text] [Related]
32. An Exploration of Mutagenesis in a Family with Cleidocranial Dysplasia without
Liu D; Liu Y; Zhang X; Wang Y; Zhang C; Zheng S
Front Genet; 2021; 12():748111. PubMed ID: 34737766
[TBL] [Abstract][Full Text] [Related]
33. miR‑488 negatively regulates osteogenic differentiation of bone marrow mesenchymal stem cells induced by psoralen by targeting Runx2.
Huang Y; Hou Q; Su H; Chen D; Luo Y; Jiang T
Mol Med Rep; 2019 Oct; 20(4):3746-3754. PubMed ID: 31485621
[TBL] [Abstract][Full Text] [Related]
34. 1,25(OH)
Jamali N; Song YS; Sorenson CM; Sheibani N
FASEB Bioadv; 2019 Jul; 1(7):415-434. PubMed ID: 31396585
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation.
Morimoto E; Li M; Khalid AB; Krum SA; Chimge NO; Frenkel B
J Cell Physiol; 2017 Jan; 232(1):145-53. PubMed ID: 27061521
[TBL] [Abstract][Full Text] [Related]
36. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.
Maeda K; Enomoto A; Hara A; Asai N; Kobayashi T; Horinouchi A; Maruyama S; Ishikawa Y; Nishiyama T; Kiyoi H; Kato T; Ando K; Weng L; Mii S; Asai M; Mizutani Y; Watanabe O; Hirooka Y; Goto H; Takahashi M
Sci Rep; 2016 Feb; 6():22288. PubMed ID: 26924503
[TBL] [Abstract][Full Text] [Related]
37. Integrated microRNA-mRNA analyses reveal OPLL specific microRNA regulatory network using high-throughput sequencing.
Xu C; Chen Y; Zhang H; Chen Y; Shen X; Shi C; Liu Y; Yuan W
Sci Rep; 2016 Feb; 6():21580. PubMed ID: 26868491
[TBL] [Abstract][Full Text] [Related]
38. Possible functional links among brain- and skull-related genes selected in modern humans.
Benítez-Burraco A; Boeckx C
Front Psychol; 2015; 6():794. PubMed ID: 26136701
[TBL] [Abstract][Full Text] [Related]
39. Novel target genes of RUNX2 transcription factor and 1,25-dihydroxyvitamin D3.
Stephens AS; Morrison NA
J Cell Biochem; 2014 Sep; 115(9):1594-608. PubMed ID: 24756753
[TBL] [Abstract][Full Text] [Related]
40. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
